# Aspirus Wausau Hospital IRB – FDA Inspection, Aug 1, 2025

Source: https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital-irb/cb2ae698-8bb0-457c-a7c3-ff3b9e1e84d0
Source feed: FDA_Inspections

> FDA inspection 1277660 of Aspirus Wausau Hospital IRB, August 01, 2025. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277660
- Company Name: Aspirus Wausau Hospital IRB
- Inspection Date: 2025-08-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Citation Count: 0

## Related Documents

- [FDA Inspection 1111975 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital-irb/4a4e80ef-05b6-43d4-95a1-14bb9c3801d9)
- FDA Inspection 936331 - 2015-07-09
- [FDA Inspection 704849 - 2010-11-18](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital-irb/48f1bbc6-c857-4047-93d4-624491ee3dc9)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/aspirus-wausau-hospital-irb/17283902-ee24-4085-82a1-df8d49c25451